PYC Therapeutics Ltd Cash Flow Conversion Efficiency

Latest as of June 2025: -0.203x

PYC Therapeutics Ltd cash flow conversion efficiency. Based on the latest financial reports, PYC Therapeutics Ltd (PYC) has a cash flow conversion efficiency ratio of -0.203x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-34.54 Million ≈ $-24.44 Million USD) by net assets (AU$170.01 Million ≈ $120.29 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of PYC Therapeutics Ltd (2004–2025)

Cash flow conversion efficiency of PYC Therapeutics Ltd from 2004 to 2025. This chart illustrates how PYC Therapeutics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View PYC Therapeutics Ltd (PYC) stock price for real-time trading data and today's change.

PYC Therapeutics Ltd Cash Flow Conversion Ratio Explained

PYC Therapeutics Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

PYC Therapeutics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PYC Therapeutics Ltd ranked by their cash flow conversion efficiency. Also see PYC stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Maccura Biotechnology Co Ltd SHE:300463	0.023x
Chutian Dragon Co Ltd SHE:003040	0.055x
CERES POWER HLDGS F:CFJ	-0.016x
Beijing Lanxum Tech Co SHE:300010	-0.071x
Shenzhen Tellus Holding Co Ltd SHE:000025	0.009x
Wuhan Zhongyuan Huadian Sci Tech SHE:300018	0.071x
Hunan Tyen Machinery Co Ltd A SHG:600698	-0.044x
NPK International Inc. NYSE:NPKI	0.059x

Annual Cash Flow Conversion Efficiency for PYC Therapeutics Ltd (2004–2025)

The table below shows the annual cash flow conversion efficiency of PYC Therapeutics Ltd from 2004 to 2025. Review PYC free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$170.01 Million ≈ $120.29 Million	AU$-51.56 Million ≈ $-36.48 Million	-0.303x	+36.30%
2024-06-30	AU$81.05 Million ≈ $57.35 Million	AU$-38.59 Million ≈ $-27.30 Million	-0.476x	+44.55%
2023-06-30	AU$28.44 Million ≈ $20.12 Million	AU$-24.42 Million ≈ $-17.28 Million	-0.859x	-58.47%
2022-06-30	AU$40.20 Million ≈ $28.45 Million	AU$-21.78 Million ≈ $-15.41 Million	-0.542x	-147.78%
2021-06-30	AU$53.92 Million ≈ $38.15 Million	AU$-11.79 Million ≈ $-8.34 Million	-0.219x	-14.86%
2020-06-30	AU$30.20 Million ≈ $21.37 Million	AU$-5.75 Million ≈ $-4.07 Million	-0.190x	+76.60%
2019-06-30	AU$6.30 Million ≈ $4.46 Million	AU$-5.13 Million ≈ $-3.63 Million	-0.814x	+80.02%
2018-06-30	AU$1.65 Million ≈ $1.17 Million	AU$-6.71 Million ≈ $-4.75 Million	-4.072x	-1815.51%
2017-06-30	AU$8.86 Million ≈ $6.27 Million	AU$-1.88 Million ≈ $-1.33 Million	-0.213x	+60.86%
2016-06-30	AU$5.83 Million ≈ $4.13 Million	AU$-3.17 Million ≈ $-2.24 Million	-0.543x	+78.94%
2015-06-30	AU$962.03K ≈ $680.70K	AU$-2.48 Million ≈ $-1.76 Million	-2.579x	-199.69%
2014-06-30	AU$3.72 Million ≈ $2.63 Million	AU$-3.20 Million ≈ $-2.26 Million	-0.861x	+55.58%
2013-06-30	AU$1.19 Million ≈ $845.45K	AU$-2.32 Million ≈ $-1.64 Million	-1.938x	-25.63%
2012-06-30	AU$2.69 Million ≈ $1.91 Million	AU$-4.15 Million ≈ $-2.94 Million	-1.542x	-128.13%
2011-06-30	AU$4.35 Million ≈ $3.08 Million	AU$-2.94 Million ≈ $-2.08 Million	-0.676x	-108.14%
2010-06-30	AU$-437.08K ≈ $-309.26K	AU$-3.63 Million ≈ $-2.57 Million	8.302x	+509.05%
2009-06-30	AU$1.91 Million ≈ $1.35 Million	AU$-3.88 Million ≈ $-2.74 Million	-2.030x	-9.99%
2008-06-30	AU$2.69 Million ≈ $1.91 Million	AU$-4.97 Million ≈ $-3.52 Million	-1.845x	-31.11%
2007-06-30	AU$2.20 Million ≈ $1.55 Million	AU$-3.09 Million ≈ $-2.19 Million	-1.407x	-5.96%
2006-06-30	AU$2.11 Million ≈ $1.50 Million	AU$-2.81 Million ≈ $-1.99 Million	-1.328x	-476.72%
2005-06-30	AU$5.78 Million ≈ $4.09 Million	AU$-1.33 Million ≈ $-942.05K	-0.230x	-549.11%
2004-06-30	AU$546.00K ≈ $386.33K	AU$28.00K ≈ $19.81K	0.051x	--

About PYC Therapeutics Ltd

AU:PYC Australia Biotechnology

Market Cap

$794.49 Million

AU$1.12 Billion AUD

Market Cap Rank

#9547 Global

#236 in Australia

Share Price

AU$1.88

Change (1 day)

-2.84%

52-Week Range

AU$1.07 - AU$2.91

All Time High

AU$2.91